Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
An Assessment of Time Toxicity in Patients Receiving [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal: The oncologist
Published: June 18, 2026
Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 15, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
Clinical Impact and Dynamics of Clonal Hematopoiesis with 177Lu-PSMA-617 Therapy in Advanced Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 20, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts.
Journal: Oncology and therapy
Published: January 09, 2026
LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: December 12, 2025
Monitoring of Disease in Patients Receiving 177LU-PSMA-617 Therapy in Routine Practice.
Journal: Clinical genitourinary cancer
Published: November 23, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
Journal: Future oncology (London, England)
Published: October 06, 2025
LASER: A Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for RCC.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 13, 2025
Fast [177Lu]Lu-PSMA SPECT/CT with dual-energy acquisition and Monte Carlo-based scatter correction.
Journal: EJNMMI physics
Published: September 01, 2025
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 08, 2025
Last Updated: 09/26/2026